HB 3639

  • Illinois House Bill
  • 103rd Regular Session
  • Introduced in House Mar 27, 2023
  • Passed House Mar 24, 2023
  • Senate
  • Became Law Aug 04, 2023

Ins-Health/Epinephrine Cost

Abstract

Amends the Accident and Health Article of the Illinois Insurance Code. Provides that an insurer that provides coverage for medically necessary epinephrine injectors shall limit the total amount that an insured is required to pay for a twin-pack of medically necessary epinephrine injectors at an amount not to exceed $60, regardless of the type of epinephrine injector. Provides that nothing in the provisions prevents an insurer from reducing an insured's cost sharing by an amount greater than the specified amount. Provides that the Department of Insurance may adopt rules as necessary to implement and administer the provisions.

Bill Sponsors (51)

Votes


Actions


Aug 04, 2023

House

Public Act . . . . . . . . . 103-0454

House

Governor Approved

House

Effective Date January 1, 2025

Jun 12, 2023

House

Added as Alternate Co-Sponsor Sen. Bill Cunningham

Jun 08, 2023

House

Sent to the Governor

May 25, 2023

House

Added as Alternate Co-Sponsor Sen. Adriane Johnson

House

Added as Alternate Co-Sponsor Sen. Rachel Ventura

House

Added as Alternate Co-Sponsor Sen. Javier L. Cervantes

House

Added as Alternate Co-Sponsor Sen. Mary Edly-Allen

House

Added as Alternate Co-Sponsor Sen. Doris Turner

May 18, 2023

House

Added as Alternate Co-Sponsor Sen. Laura M. Murphy

May 15, 2023

House

Added as Alternate Co-Sponsor Sen. Elgie R. Sims, Jr.

May 11, 2023

House

Added as Alternate Co-Sponsor Sen. Andrew S. Chesney

May 10, 2023

House

Added as Alternate Co-Sponsor Sen. Erica Harriss

House

Added as Alternate Co-Sponsor Sen. Terri Bryant

House

Added as Alternate Co-Sponsor Sen. Sally J. Turner

House

Passed Both Houses

House

Third Reading - Passed; 056-000-000

House

Added as Alternate Co-Sponsor Sen. Steve Stadelman

House

Added as Alternate Co-Sponsor Sen. Paul Faraci

May 09, 2023

House

Added as Alternate Co-Sponsor Sen. David Koehler

May 02, 2023

House

Added as Alternate Co-Sponsor Sen. Celina Villanueva

House

Placed on Calendar Order of 3rd Reading May 3, 2023

House

Second Reading

Apr 28, 2023

House

Added as Alternate Co-Sponsor Sen. Meg Loughran Cappel

Apr 27, 2023

House

Added as Alternate Co-Sponsor Sen. Robert F. Martwick

Apr 26, 2023

House

Do Pass Insurance; 008-000-000

House

Added as Alternate Chief Co-Sponsor Sen. Christopher Belt

House

Placed on Calendar Order of 2nd Reading April 27, 2023

Apr 25, 2023

House

Added as Alternate Co-Sponsor Sen. Suzy Glowiak Hilton

Apr 18, 2023

House

Added as Alternate Chief Co-Sponsor Sen. Julie A. Morrison

House

Assigned to Insurance

Mar 27, 2023

House

Referred to Assignments

House

Chief Senate Sponsor Sen. Michael W. Halpin

House

Placed on Calendar Order of First Reading

House

Arrive in Senate

House

First Reading

Mar 24, 2023

House

Third Reading - Short Debate - Passed 102-001-000

House

Placed on Calendar Order of 3rd Reading - Short Debate

House

House Floor Amendment No. 2 Adopted

House

Added Co-Sponsor Rep. Michelle Mussman

Mar 23, 2023

House

Added Co-Sponsor Rep. Maura Hirschauer

House

House Floor Amendment No. 2 Recommends Be Adopted Prescription Drug Affordability & Accessibility Committee; 011-000-000

House

Added Chief Co-Sponsor Rep. Jonathan Carroll

House

Added Co-Sponsor Rep. Sharon Chung

House

Added Co-Sponsor Rep. La Shawn K. Ford

House

Added Co-Sponsor Rep. Camille Y. Lilly

House

Added Co-Sponsor Rep. Will Guzzardi

House

Added Co-Sponsor Rep. Anna Moeller

House

Added Co-Sponsor Rep. Mary E. Flowers

House

Added Co-Sponsor Rep. Maurice A. West, II

House

Added Co-Sponsor Rep. Laura Faver Dias

House

Added Co-Sponsor Rep. Daniel Didech

Mar 22, 2023

House

House Floor Amendment No. 2 Filed with Clerk by Rep. Joyce Mason

House

Held on Calendar Order of Second Reading - Short Debate

House

Second Reading - Short Debate

House

House Floor Amendment No. 2 Rules Refers to Prescription Drug Affordability & Accessibility Committee

House

Added Co-Sponsor Rep. Stephanie A. Kifowit

House

Added Co-Sponsor Rep. Rita Mayfield

House

Added Chief Co-Sponsor Rep. Sue Scherer

House

House Floor Amendment No. 2 Referred to Rules Committee

Mar 21, 2023

House

Added Co-Sponsor Rep. Janet Yang Rohr

Mar 16, 2023

House

Added Co-Sponsor Rep. Martin McLaughlin

Mar 09, 2023

House

House Committee Amendment No. 1 Rules Refers to Prescription Drug Affordability & Accessibility Committee

House

Placed on Calendar 2nd Reading - Short Debate

House

House Committee Amendment No. 1 Tabled

House

Do Pass / Short Debate Prescription Drug Affordability & Accessibility Committee; 013-000-000

House

Added Co-Sponsor Rep. Harry Benton

House

Added Co-Sponsor Rep. Carol Ammons

House

Added Co-Sponsor Rep. Suzanne M. Ness

House

Added Chief Co-Sponsor Rep. Dagmara Avelar

Mar 08, 2023

House

Added Co-Sponsor Rep. Anne Stava-Murray

House

House Committee Amendment No. 1 Referred to Rules Committee

House

House Committee Amendment No. 1 Filed with Clerk by Rep. Joyce Mason

House

Added Co-Sponsor Rep. Jenn Ladisch Douglass

House

Added Co-Sponsor Rep. Lilian Jiménez

House

Added Co-Sponsor Rep. Matt Hanson

House

Added Co-Sponsor Rep. Mary Beth Canty

House

Added Chief Co-Sponsor Rep. Jawaharial Williams

Mar 06, 2023

House

Added Co-Sponsor Rep. Terra Costa Howard

House

Removed Co-Sponsor Rep. Jonathan Carroll

House

Added Co-Sponsor Rep. Jonathan Carroll

Feb 28, 2023

House

Assigned to Prescription Drug Affordability & Accessibility Committee

Feb 17, 2023

House

First Reading

House

Referred to Rules Committee

House

Filed with the Clerk by Rep. Joyce Mason

Bill Text

Bill Text Versions Format
Introduced HTML PDF
Engrossed HTML PDF
Enrolled HTML PDF
House Amendment 001 HTML PDF
House Amendment 002 HTML PDF

Related Documents

Document Format
Public Act

Sources

Data on Open States is updated periodically throughout the day from the official website of the Illinois General Assembly.

If you notice any inconsistencies with these official sources, feel free to file an issue.